This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Industry professionals will explore the market, innovative formulations and nutritional solutions tailored to empower women toward optimal health and well-being. A significant 58 percent of women worldwide have heightened their use of supplements to support overall wellness.
With this has come an increase in the size of the global clinical trials market, with an estimated worth of around $46.8 In 2019 alone, worldwide pharma revenues totaled $1.25 trillion, with oncologics accounting for $99.5 billion in 2019.
Next-generation sequencing (NGS) allows for efficient analysis of known genetic mutations, enhancing diagnostic accuracy. Overall, the diagnostic process for LOPD typically involves a series of assessments, including clinical, laboratory and imaging tests, culminating in geneticanalysis to confirm the diagnosis.
The global market for cell and gene therapies , valued at $5.9 The market for molecular diagnostics was valued at $25 billion in 2022 and is projected to grow at a CAGR of over 3.5 The global stem cell market was valued at $15.07 The global next-generation biomanufacturing market is projected to grow at a CAGR of 14.85
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content